Grow Therapy IPO

growtherapy.comHealthcare / Digital Health

Grow Care, Inc., operating under the brand name Grow Therapy aims to support independent therapists in establishing and helping expand their own in-network private practices. This support includes handling large-scale credentialing, referrals, and administrative tasks, with a mission to help therapists focus more on their patients without the burden of administrative overhead. Grow Therapy was founded by Alan Ni, Jake Cooper, and Manoj Kanagaraj in 2020 and is headquartered in New York, NY.

Buy or sell Grow Therapy stock Learn more about Grow Therapy stock

Learn more about Grow Therapy

Is Grow Therapy a publicly traded company?

Grow Therapy is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Will Grow Therapy go IPO?

Grow Therapy has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Grow Therapy's IPO price?

The IPO price for Grow Therapy will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.

Can you invest in Grow Therapy pre-IPO?

Grow Therapy is privately held company and is not publicly traded, therefor investing in Grow Therapy pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

What is the value of my Grow Therapy shares?

To determine the value of your Grow Therapy shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Grow Therapy shares. You can also learn more about how to sell your private shares before getting started.

Can you sell Grow Therapy before it goes public?

Yes, you can seek to sell shares in Grow Therapy while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

When was Grow Therapy founded?

Grow Therapy was founded in 2020.

Who are Grow Therapy's major investors?

Sequoia Capital

TCV

Goldman Sachs Asset Management

Struck Capital

SignalFire

Transformation Capital

Maven Ventures

SVB Financial Group

What If Ventures

Village Global

Plus Capital

Alpha Edison

Mana Ventures

Harvard Innovation Launch Lab

North 50 Venture Capital

Free Solo Ventures

Reshape Ventures

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.